Overexpression of LRIG1 in LNCaP AI cells exhibited inhibitory effects on both tumor incidence and growth (Fig. 5g) whereas knocking down endogenous LRIG1 in LAPC9 AI cells promoted both tumor regeneration and growth in a limiting-dilution tumor assay (Fig. 5h). The gene discussed is LRIG1; the disease is neoplasm.